Latest news and views from PBD Biotech about the detection, identification and eradication of tuberculosis and related mycobacterial diseases.
Loading...
May 12, 2022
The findings are a real breakthrough for animal diagnosis as it provides clinical evidence that detection of low levels of mycobacteria in the blood is an indication that the animal is infected and has the potential to develop disease.
The findings are a real breakthrough for animal diagnosis as it provides clinical evidence that detection of low levels of...
April 7, 2022
A new rapid testing service from PBD Biotech will enable farmers to find out in days if a bulk milk or blood sample contains MAP, the bacteria that causes Johne's Disease an economically devastating disease.
A new rapid testing service from PBD Biotech will enable farmers to find out in days if a bulk milk...
March 23, 2022
Sub-Saharan Africa is devastated by TB disease. Zambia, has a high TB/HIV burden – 59,000 people developed TB in 2020 and 15,000 died. There is a critical need for a non-sputum based rapid test for diagnosing TB disease.
March 23, 2022
Sub-Saharan Africa is devastated by TB disease. Zambia, has a high TB/HIV burden – 59,000 people developed TB in 2020...
March 7, 2022
Bacteriophages, viruses that infect and kill bacteria, offer the potential of a powerful tool for detecting and treating mycobacterial infections such as tuberculosis (TB), authors of a review in the journal Microorganisms* have reported.
Bacteriophages, viruses that infect and kill bacteria, offer the potential of a powerful tool for detecting and treating mycobacterial infections...
February 24, 2022
Phage diagnostics have potential for cost-effective detection of bacterial infections across medical, food, and agricultural industries says new review.
February 24, 2022
Phage diagnostics have potential for cost-effective detection of bacterial infections across medical, food, and agricultural industries says new review.
February 14, 2022
Of the 10 million individuals who became ill with 'active' TB in 2018, approximately three million were missed by health systems, according to the Centres for Disease Control and Prevention (CDC)
February 14, 2022
Of the 10 million individuals who became ill with 'active' TB in 2018, approximately three million were missed by health...
January 27, 2022
PBD Biotech is expanding its North American team. Tuberculosis (TB) and Johne’s Disease expert Tom Kellner has been appointed as Director of Operations in North America, to advise on regulatory affairs and provide technical and customer support.
January 27, 2022
PBD Biotech is expanding its North American team. Tuberculosis (TB) and Johne’s Disease expert Tom Kellner has been appointed as...
January 26, 2022
Johne's Disease, is a wasting disease caused by MAP. A sensitive test for assessing milk samples would be a useful quality assurance tool.
January 26, 2022
Johne's Disease, is a wasting disease caused by MAP. A sensitive test for assessing milk samples would be a useful...
January 18, 2022
“PBD Biotech has developed an exciting and potentially disruptive technology that uses bacteriophage to improve the molecular diagnosis of tuberculosis” says Dr Tomas Richardson.
January 18, 2022
“PBD Biotech has developed an exciting and potentially disruptive technology that uses bacteriophage to improve the molecular diagnosis of tuberculosis”...
January 17, 2022
Innovation directed at an unmet market need can stimulate economic development if the value creation is kept within the local economy. The recent pandemic has shown the huge value of diagnostics and tuberculosis (TB), for which there are currently few...
Innovation directed at an unmet market need can stimulate economic development if the value creation is kept within the local...
December 10, 2021
PBD Biotech, developers of a phage-based diagnostic for tuberculosis, is moving to the next stage of its development. It is appointing Jane Theaker, of precision medicine company Kinomica, as the new CEO and bringing Commercial Director, Jonnie Yewdall, into a...
PBD Biotech, developers of a phage-based diagnostic for tuberculosis, is moving to the next stage of its development. It is...
September 22, 2021
Albert’s research, ‘Use of 2, 3, 5-Triphenyltetrazolium chloride (TTC) to assay the kinetics of phage and host interactions’, is sponsored by PBD Biotech through the BBSRC CASE initiative, and was co-authored by fellow Nottingham student Philip J. Hill and PBD...
September 22, 2021
Albert’s research, ‘Use of 2, 3, 5-Triphenyltetrazolium chloride (TTC) to assay the kinetics of phage and host interactions’, is sponsored...